In this video, I go through Sangamo's updated data with their Hemophilia A and Beta-Thalassemia treatments. I also talk about Viking Therapeutics' VK5211, a potent selective androgen receptor modulator. Follow me @matthewlepoire This is not investment advice www.breakingbiotech.com breakingbiotech #SGMO #VKTX